PHARMLY ANALYTICS

Reimagine healthcare data analytics

Pharmly Analytics gives access to UK pharmaceutical market intelligence. With all main healthcare data available and the option to build your own dashboard view this is the tool you need when you want to analyse the market.

Pharmly Analytics 3.0

We're very proud to announce the release of Pharmly Analytics 3.0 featuring a new intelligent analytics engine that will give you a complete overview of all your selected products in our AI Console. At a glance, you will see valuable market opportunities, primary and secondary care prescribing trends, branded versus generic prescribing rates, recent price changes, newly granted licenses and much more. Never miss a new market entry, a price change or concessionary listing. Reimagine healthcare data analytics!

Our App

Pharmly Analytics is trusted by multiple pharmaceutical companies as their pharmaceutical market intelligence tool. Whether you're a sales manager, portfolio analyst or business development manager, Pharmly Analytics helps you to efficiently assess the competitive landscape. With advanced filter and search options, you're just seconds away from finding the right information!

Prescribing Analysis

Our Prescribing Analysis identifies growth in volume and cost of prescribing in the UK as well as generic and branded prescription rates. Our enriched prescribing data enables healthcare companies to better understand pharmaceutical prescribing trends so they can identify opportunities. With a simple search by active ingredient, product and/or strength we make it easy to navigate through all prescriptions written in primary care across England, Scotland, Wales and Northern Ireland.

Pricing Trends

Pharmly Analytics offers access to Drug Tariff and List Prices in England. The Drug Tariff price, is the rate that the Department of Health reimburses pharmacies for prescription medications. Company-specific list prices tell us a great deal of information about market demand and corporate strategy. You can rely on this information to plan product launches and monitor competition.

Our Pricing Trends contains trend analysis for over 1,100 active ingredients and 90,000 product packs for over 400 weeks!

Dictionary of Medicines and Devices (DM+D): explore the market

The DM+D contains all the medicines and devices used across the NHS. When any company would like to provide a medication or medical device they must first register their product, including detailed characteristics, with the DM+D. Our DM+D tracker gives you the latest information about newly registered products and products packs and the number of active companies, and our DM+D Browser allows you to easily search for any product or company.

Licensing: Market Authorisations

All pharmaceutical companies are legally required to obtain a Marketing Authorisation for every product that they wish to launch. In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for issuing Marketing Authorisations. In the Licensing section of Pharmly Analytics you search by company or product to see all granted and cancelled licenses. Besides information about the status of a license, Pharmly Analytics offers direct access to all Patient Information Leaflets (PIL), Summary Of Product Characteristics documents (SPC) and the Public Assessment Report (PAR) for each Marketing Authorisation granted.

Pharmly Analytics is fully customisable to your needs

Besides offering dozens of out-of-box analyses, Pharmly Analytics also offers you the option to tailor any analysis. Our AI Console enables you to load any set of products so you always get information and opportunities that matter to you. Besides that, by using our built-in pivot table functionality, you can quickly do cross-analysis on whatever dataset you choose. And if that's not tailored enough, you can always download part of our preprocessed datasets to analyse the data further.

Opportunities & Budget Impact Models

Pharmly Analytics 3.0 analyses every dataset and finds out which Clinical Commission Groups (Integrated Care Boards) might benefit most from switching to one of your brands, which additional products might be worthwhile to launch, where there are emerging trends, how you can reduce packaging materials and much more! Our opportunities contribute to our mission to accelerate innovation in healthcare by identifying unique opportunities to deliver better healthcare and reduce the NHS cost burden.

Pricing and Plans

Reimagine healthcare data analytics. Choose Pharmly Analytics and start with a one-week free trial.

Features Base Premium ⭐️
UK Prescribing analysis
Branded and generic tracking
DM&D browser and tracker
Pricing analysis (Drug Tariff, List Prices, Concessionary Prices)
Marketing Authorisations (including SCP, PIL and PAR documents)
Opportunities for your chosen set(s) of products
Dashboard including option to make your own product lists and portfolios
Monthly Drug Tariff and List Pricing email reports for your company
Premium support
Users 5 5
Price per month £ 1250 £ 1750
Price per additional user (per month) £ 250 £ 350

Are you a small business, student, NHS affiliate, researcher, or are you using our data for the greater good? Please contact us to see where we can help you out!

Can’t choose between Pharmly Analytics and Pharmly Cloud Data? We offer a 20% discount when you’re making use of both!